Drugmaker Regeneron to acquire 23andMe out of bankruptcy

washingtonpost.com/business/2025/05/19/23andme-bankruptcy-acquisition-regeneron

The pharmaceutical giant plans to continue offering 23andMe’s DNA testing service and pledged to adopt its privacy practices to protect customer data.

This story appeared on washingtonpost.com, 2025-05-19 14:19:11.
The Entire Business World on a Single Page. Free to Use →